<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Antibiotic Nanozyme Research</title>
    <link rel="stylesheet" href="index.style.css">
</head>
<body>
    <!-- 全屏视频开场 -->
    <div id="video-intro">
        <video autoplay muted id="intro-video">
            <source src="video/3.mp4" type="video/mp4">
            <!-- 备用图片，如果视频无法播放 -->
            <img src="sucai/4.png" alt="Intro Image">
        </video>
        <button id="skip-intro">Skip Intro</button>
    </div>

    <!-- 主页面内容 -->
    <div id="main-content" class="hidden">
        <!-- 导航栏 -->
        <header>
            <nav class="nav-container">
                <div class="logo">Antibiotic Nanozyme</div>
                <ul class="nav-menu">
                    <li class="nav-item"><a href="index.html" class="nav-link">Home</a></li>
                    <li class="nav-item"><a href="project.html" class="nav-link">Project</a></li>
                    <li class="nav-item"><a href="design.html" class="nav-link">Design</a></li>
                    <li class="nav-item"><a href="feasibility.html" class="nav-link">Feasibility</a></li>
                    <li class="nav-item"><a href="method.html" class="nav-link">Method</a></li>
                    
                    <li class="nav-item"><a href="result.html" class="nav-link">Result</a></li>
                    <li class="nav-item"><a href="about.html" class="nav-link">About Us</a></li>
                    <li class="nav-item"><a href="future.html" class="nav-link">Future</a></li>
                    <li class="nav-item"><a href="elsi.html" class="nav-link">ELSI</a></li>
                </ul>
                <div class="hamburger">
                    <span class="bar"></span>
                    <span class="bar"></span>
                    <span class="bar"></span>
                </div>
            </nav>
        </header>

        <!-- 英雄区域 -->
        <section class="hero">
            <div class=""></div>
            <!-- 左上角图片 -->
            <div class="hero-corner-image">
                <img src="sucai/attic.png" alt="左上角图片">
            </div>
            <div class="hero-content">
                <div class="hero-text">
                    <h1>A Novel Strategy to Combat Antimicrobial Resistance via Molecular Co-Assembly</h1>
                </div>
                
            </div>
        </section>

        <!-- 内容区域 -->
        <main class="content">
            <!-- 第一部分 - 恢复正常布局 -->
            <section class="section section-1" id="section1">
                <div class="section-content">
                    <div class="section-text">
                        <h2>The Challenge of Antimicrobial Resistance (AMR)</h2>
                        <p>AMR represents one of the most serious global public health threats of the modern era, responsible for at least 1 million deaths annually worldwide—a figure anticipated to increase progressively <sup>[1]</sup>. Scientific research indicates that this crisis stems not only from the spread of resistant bacterial strains but also from complex underlying biological mechanisms: firstly, bacteria can efficiently transfer resistance genes via plasmids, with certain "superplasmids" capable of conferring resistance to multiple first-line and even last-resort antibiotics<sup>[2]</sup>; secondly, some pathogens may paradoxically enhance their virulence by discarding specific resistance mechanisms, potentially increasing disease severity and patient mortality<sup>[3]</sup>. Compounding this issue, no truly novel class of antibiotics has been introduced into clinical use since the 1990s—a gap exceeding three decades, leading to a significantly depleted antimicrobial arsenal. Consequently, the development of innovative therapeutic strategies to address the current treatment impasse has become an urgent global imperative.</p>
                    </div>
                    <div class="section-image">
                        <img src="home.move/tt.jpg">
                        <div class="carousel-container">
                            <div class="image-container">
                                <!-- 图片2 -->
                                <div class="image-frame">
                                    <div class="placeholder">
                                        <img src="home.move/1.jpg">
                                    </div>
                                </div>
                                
                                <!-- 图片3 -->
                                <div class="image-frame">
                                    <div class="placeholder">
                                        <img src="home.move/2.jpg">
                                    </div>
                                </div>
                                
                                <!-- 图片4 -->
                                <div class="image-frame">
                                    <div class="placeholder">
                                        <img src="home.move/3.jpg">
                                    </div>
                                </div>
                            </div>
                            
                            <div class="carousel-caption">
                                Fig.1 Bloodstream infections with third-generation cephalosporins (<i>E. coli</i>) or methicillin resistance (<i>S. aureus</i>) susceptibility test results reported to GLASS-AMR, per one million population (2016, 2018, 2020)<sup>[4]</sup>.
                            </div>
                        </div>
                    </div>
                </div>
            </section>

            <!-- 第二部分 -->
            <section class="section section-2" id="section2">
                <div class="section-content">
                    <div class="section-text">
                        <h2>The Application of Nanozymes in Combating AMR</h2>
                        <p>Nanozymes, a class of artificial nanomaterial exhibiting enzyme-mimetic catalytic properties, are increasingly recognized as promising agents in combating AMR and have emerged as a frontier research domain with transformative potential<sup>[5]</sup>. These nanozymes can generate reactive oxygen species (ROS) and other antibacterial agents via catalytic reactions, resulting in direct damage to bacterial cell membranes, DNA, and other essential cellular components, thereby enable the effective elimination of various drug-resistant pathogens, such as methicillin-resistant <i>Staphylococcus aureus</i> (MRSA)<sup>[6-7]</sup>. More importantly, their multi-mechanistic physicochemical bactericidal mode makes it difficult for bacteria to develop resistance, offering a promising avenue to address the current AMR crisis.</p>
                        <p>Furthermore, nanozymes exhibit the capacity to penetrate and disrupt robust bacterial biofilms, a characteristic critical for the effective management of chronic and persistent infections. The immobilization of nanozymes on medical dressings has been shown to achieve over 90% elimination of <i>Candida albicans</i> within 10 minutes<sup>[8]</sup>, indicating their strong antimicrobial efficacy and considerable potential for practical clinical applications. Consequently, nanozymes can be regarded as a powerful tool in confronting the challenges of the "post-antibiotic era"<sup>[7]</sup>.</p>
                    </div>
                    <div class="section-image">
                        <img src="home/2.png" alt="Fig. 2. Schematic representation of catalytic activity" style="width: 600px; height: 340px; background-color: #e0e0e0; display: block; margin: 0 auto;">
                        <p style="font-size: 0.85rem;"> Fig.2  IUPAC Top Ten Emerging Technologies in Chemistry 2022</p>
                    </div>
                </div>
            </section>

            <!-- 第三部分 -->
            <section class="section section-3" id="section3">
                <div class="section-content">
                    <div class="section-text">
                        <h2>Design and Synthesis of a Novel Antibiotic Nanozymes</h2>
                        <h3>Herein, we report the design of a novel class of antibiotic nanozymes via molecular co-assembly of antibiotics with hemin chloride, aimed at addressing AMR<sup>[9]</sup>.</h3>
                        <p>The synthesis of these antibiotic nanozymes exhibits exceptional versatility. A series of representative antibiotics were selected, including gentamicin (GM) and fluconazole (FCZ), along with virtual screening of molecular candidates such as rapamycin (RAPA) and ceftriaxone.Each of these antibiotics effectively co-assembled with hemin chloride through axial coordination and copolymerization, resulting in the formation of stable antibiotic nanozymes.</p>
                    </div>
                    <div class="section-image">
                        <img src="home/home.3.jpg" alt="Fig. 3. Assembly of antibiotics and hemin" style="width: 325px; height: 300px; background-color: #e0e0e0; display: block; margin: 0 auto;">
                        <p style="font-size: 0.85rem;">Fig.3 Schematic diagram of the assembly of various antibiotics and hemin into antibiotic nanozymes</p>
                    </div>
                </div>
            </section>

            <!-- 第四部分 -->
            <section class="section section-4" id="section4">
                <div class="section-content">
                    <div class="section-text">
                        <h2>One of the Antibacterial Mechanisms of Antibiotic Nanozymes </h2>
                        <p>The antibiotic nanozymes exert potent bactericidal effects through the following multifaceted mechanisms<sup>[10]</sup>:</p>
                        <ol style="list-style-type: none;">
                            <li>(1) effective degradation of bacterial biofilms<sup>[11]</sup>;</li>
                            <li>(2) induction of oxidative damage in bacterial cells via peroxidase (POD)-like activity; </li>
                            <li>(3) promotion of bacterial ferroptosis by functioning as ferroptosis inducers<sup>[12]</sup>; </li>
                            <li>(4) intracellular release of constituent antibiotics, enabling synergistic antibacterial effects.</li>
                        </ol>
                    </div>
                    <div class="section-image">
                        <img src="home/home.4.png" alt="Fig. 4. Antibacterial mechanism of nanozymes" style="width: 396px; height: 350px; background-color: #e0e0e0; display: block; margin: 0 auto;">
                        <p style="font-size: 0.85rem;">Fig.4 Schematic diagram of the antibacterial mechanism of nanozymes</small></p>
                    </div>
                </div>
            </section>
        </main>

        <!-- 参考文献 -->
        <section class="references">
            <h2>References</h2>
                <ul style="list-style-type: none; padding-left: 0;">
                    <li style="margin-bottom: 10px;">[1]Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-655. doi:10.1016/S0140-6736(21)02724-0</li>
                    <li style="margin-bottom: 10px;">[2]Cazares A, Figueroa W, Cazares D, et al. Pre- and postantibiotic epoch: The historical spread of antimicrobial resistance. Science. Published online September 25, 2025. doi:10.1126/science.adr1522</li>
                    <li style="margin-bottom: 10px;">[3]Fernandes SE, Ortega H, Vaillancourt M, et al. Evolutionary loss of an antibiotic efflux pump increases Pseudomonas aeruginosa quorum sensing mediated virulence in vivo. Nat Commun. 2025;16(1):8397. Published 2025 Sep 25. doi:10.1038/s41467-025-63284-7</li>
                    <li style="margin-bottom: 10px;">[4]Global antimicrobial resistance and use surveillance system (GLASS) report 2022. Geneva: World Health Organization; 2022.</li>
                    <li style="margin-bottom: 10px;">[5]Yuan Y, Chen L, Song K, et al. Stable peptide-assembled nanozyme mimicking dual antifungal actions. Nat Commun. 2024;15(1):5636. Published 2024 Jul 5. doi:10.1038/s41467-024-50094-6</li>
                    <li style="margin-bottom: 10px;">[6]Zhu X, Lu W, Li Z, et al. Nanozyme-based synergistic therapy: FeCo-NC for effective bacterial eradication and wound tissue regeneration. J Colloid Interface Sci. 2025;699(Pt 1):138125. doi:10.1016/j.jcis.2025.138125</li>
                    <li style="margin-bottom: 10px;">[7]Zheng H, Huarong X, Yiduo D, et al. Nanozymes in the field of antibacterial applications: mechanisms and optimization strategies. Coord Chem Rev . 2025;543:216939. doi:10.1016/j.ccr.2025.216939</li>
                    <li style="margin-bottom: 10px;">[8]Zhang SJ, Xu R, He SB, Sun R, Wang GN, Wei SY, et al. Nanozyme-driven multifunctional dressings: moving beyond enzyme-like catalysis in chronic wound treatment. Mil Med Res. Published online May 31, 2025. doi:10.1186/s40779-025-00611-5</li>
                    <li style="margin-bottom: 10px;">[9]Liu H, Yang Y, Wang P, et al. Microenvironment-activated nanozyme-armed bacteriophages efficiently combat bacterial infection. Adv Mater. 2023;35(51):2307132. doi:10.1002/adma.202307132</li>
                    <li style="margin-bottom: 10px;">[10]Fang G, Li W, Shen X, Perez-Aguilar JM, Chong Y, Gao X, et al. Differential Pd-nanocrystal facets demonstrate distinct antibacterial activity against Gram-positive and Gram-negative bacteria. Nat Commun. 2018;9:129. doi:10.1038/s41467-017-02502-3</li>
                    <li style="margin-bottom: 10px;">[11]Chung JY, Hong YK, Jeon E, Yang S, Park A, Weissleder R, et al. Effective treatment of systemic candidiasis by synergistic targeting of cell wall synthesis. Nat Commun. Published online July 1, 2025. doi:10.1038/s41467-025-60684-7</li>
                    <li style="margin-bottom: 10px;">[12]Liu Y, Zhang J, Li B, et al. Advanced nanozymes possess peroxidase-like catalytic activities in biomedical and antibacterial fields: review and progress. J Mater Chem B. 2023;11(48):11514-11539. doi:10.1039/D3TB02123K</li>
                </ul>
        </section>

        <!-- 页脚 -->
        <footer>
            <div class="footer-content">
                <p>&copy; 2025 Antibiotic Nanozyme Research Project. </p>
                
            </div>
        </footer>
    </div>

    <script src="index.scripts.js"></script>
</body>
</html>